--- topic: "Vitamin D" title: "Supplementation guide" order: 3 description: "D3 vs D2, dosing recommendations, testing, and safety considerations" question: "How much vitamin D3 should I take, and how often?" answer: "Daily vitamin D3 at 1,000 to 2,000 IU likely maintains levels better than D2, and large monthly doses raised falls in one trial." actions: - "Choose D3 (cholecalciferol) over D2 and take it daily with a fat-containing meal; D3 raised peak levels 87% higher in a trial [1]." - "Get a 25(OH)D blood test, ideally in late winter, and retest after 3 months aiming for 30–50 ng/mL [2]." - "Most adults do well on 1,000–2,000 IU daily; daily or weekly dosing beats large monthly doses [4]." cautions: - "Monthly 60,000 IU raised falls in adults over 70 (66.9% vs 47.9% with 24,000 IU) despite higher blood levels [4]." - "Toxicity is rare below 10,000 IU a day but can raise calcium and damage kidneys; the official upper limit is 4,000 IU [2][3]." - "Supplements mainly help people who are deficient; benefits beyond bone health in replete people remain limited [5]." confidence: 3 confidenceNote: "D3 over D2 rests on a 33-person trial, the falls finding on one 200-person RCT; doses follow a guideline." evidenceSummary: rctCount: 2 observationalCount: 0 metaAnalysisCount: 1 totalParticipants: "230+" replicated: true newestStudyYear: 2024 references: - id: "1" pmid: "21177785" title: "Vitamin D(3) is more potent than vitamin D(2) in humans" authors: "Heaney RP, Recker RR, Grote J, Horst RL, Armas LA" year: 2011 journal: "Journal of Clinical Endocrinology and Metabolism" - id: "2" pmid: "21646368" title: "Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline" authors: "Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM" year: 2011 journal: "Journal of Clinical Endocrinology and Metabolism" - id: "3" url: "https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/" title: "Vitamin D - Fact Sheet for Health Professionals" authors: "NIH Office of Dietary Supplements" year: 2024 journal: "NIH Office of Dietary Supplements" - id: "4" pmid: "26747333" title: "Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial" authors: "Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, Staehelin HB, Meyer OW, Theiler R, Dick W, Willett WC, Egli A" year: 2016 journal: "JAMA Internal Medicine" - id: "5" pmid: "29102433" title: "Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials" authors: "Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K, Pizot C, Boniol M" year: 2017 journal: "Lancet Diabetes and Endocrinology" --- If you do not get regular sun exposure, a vitamin D supplement is one of the simplest things you can do for your health. Vitamin D3 is the preferred form, and most adults do well with 1,000 to 2,000 IU daily. It is inexpensive, widely available, and very safe at recommended doses. A simple blood test can tell you where you stand. Ask your doctor for a 25-hydroxyvitamin D test if you have not had one recently. Take your supplement with a meal that contains some fat, since vitamin D is fat-soluble and absorbs better that way. ### D3 vs D2 Vitamin D comes in two supplemental forms: D3 (cholecalciferol, from animal sources or lichen) and D2 (ergocalciferol, from fungi). While both raise serum 25(OH)D levels, D3 is significantly more effective. A head-to-head trial showed that D3 was approximately 87% more potent than D2 in raising and maintaining serum 25(OH)D concentrations, and D3 produced 2-3 times greater storage of vitamin D in the body [1]. D2 also has a shorter half-life and is less stable in storage. For these reasons, the Endocrine Society and most clinical guidelines recommend D3 for supplementation [2]. ### Dosing recommendations The Endocrine Society recommends [2]: | Population | Daily dose | |---|---| | Adults 19-50 | 600-1,000 IU (minimum); 1,500-2,000 IU preferred | | Adults 50-70 | 600-1,000 IU (minimum); 1,500-2,000 IU preferred | | Adults 70+ | 800-1,000 IU (minimum); 1,500-2,000 IU preferred | | Obese adults | 2-3x higher (often 3,000-6,000 IU) | | Pregnant/lactating | 600-1,000 IU (minimum); 1,500-2,000 IU preferred | The tolerable upper intake level (UL) set by the Institute of Medicine is 4,000 IU/day for adults, though the Endocrine Society notes that up to 10,000 IU/day is safe for most adults without risk of toxicity [2][3]. ### Testing and target levels The standard test is serum 25-hydroxyvitamin D [25(OH)D]. The Endocrine Society defines [2]: - **Deficient**: below 20 ng/mL (50 nmol/L) - **Insufficient**: 21-29 ng/mL (52.5-72.5 nmol/L) - **Sufficient**: 30 ng/mL or above (75 nmol/L) Testing is recommended for individuals at high risk of deficiency: those with limited sun exposure, darker skin, obesity, malabsorption conditions, or those taking medications that affect vitamin D metabolism (anticonvulsants, glucocorticoids, antifungals) [2]. ### Dosing frequency Daily dosing is preferred over large intermittent doses. A randomized trial found that monthly high-dose vitamin D (60,000 IU) actually increased fall risk compared to a standard monthly dose (24,000 IU), despite achieving higher serum levels [4]. The mechanism may involve transient spikes in calcitriol that paradoxically impair muscle function. Daily or weekly dosing maintains steadier serum levels and avoids this problem. ### D3 superiority: the evidence base Heaney et al. (2011) conducted a controlled trial in 33 healthy adults comparing single doses of 50,000 IU of D2 vs D3 [1]. D3 produced a peak serum 25(OH)D that was 87% higher than D2, and the area under the curve over 28 days was approximately three times greater. The biological explanation lies in differential binding affinity: D3 binds more effectively to vitamin D-binding protein (DBP) in circulation and is preferentially 25-hydroxylated in the liver. D2 also produces 25(OH)D2, which has a shorter circulating half-life (approximately 13-15 days vs. 25 days for 25(OH)D3) and may not be measured equally well by all commercial assays, leading to underestimation of status when D2 is the supplemental form. ### Safety and toxicity Vitamin D toxicity is rare and has not been reported at daily intakes below 10,000 IU in adults [2][3]. Toxicity manifests as hypercalcemia, with symptoms including nausea, vomiting, weakness, and kidney damage. Most documented cases involve prolonged daily intake exceeding 40,000-50,000 IU or industrial manufacturing errors in supplement potency. The Autier et al. (2017) systematic review in the Lancet examined 83 meta-analyses and 30 subsequent RCTs and concluded that while vitamin D supplementation corrects deficiency states, evidence for benefits beyond skeletal health in vitamin D-replete populations remains limited [5]. This finding is important for clinical practice: supplementation is most impactful for individuals who are actually deficient, rather than as a universal pharmacological intervention. ### The intermittent dosing problem The Bischoff-Ferrari et al. (2016) trial randomized 200 community-dwelling adults aged 70 and older to receive monthly doses of either 24,000 IU or 60,000 IU of vitamin D3 for one year [4]. The high-dose group achieved higher mean 25(OH)D levels (45 vs. 37 ng/mL) but had a significantly higher rate of falls (66.9% vs. 47.9%, p=0.048). This finding replicated concerns from earlier bolus-dosing trials and reinforced that physiological daily doses (1,000-4,000 IU) are preferable to pharmacological intermittent loading. ### Practical supplementation protocol Based on the totality of evidence [1][2][3][4][5], a reasonable approach for most adults is: 1. **Test**: Get a baseline 25(OH)D level, ideally in late winter when levels are lowest. 2. **Supplement with D3**: 1,000-2,000 IU daily for maintenance if levels are above 30 ng/mL. For deficiency (below 20 ng/mL), the Endocrine Society recommends 50,000 IU weekly for 8 weeks as a loading dose, followed by 1,500-2,000 IU daily for maintenance [2]. 3. **Take with fat**: Co-ingestion with a fat-containing meal increases absorption by approximately 50%. 4. **Retest after 3 months**: Confirm levels have reached the target range of 30-50 ng/mL. 5. **Consider cofactors**: Adequate magnesium is required for vitamin D metabolism. Vitamin K2 may complement vitamin D's effects on calcium metabolism, though RCT evidence for the combination is still developing.